Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1152 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Triheptanoin for long-chain fatty acid oxidation disorders	Triheptanoin (UX007; Dojolvi)	Long chain fatty acid oxidation disorders (LC-FAOD)	Endocrine Nutritional and Metabolic Disorders	2021	View \| Download
Triheptanoin for long chain fatty acid oxidation disorders	Triheptanoin (UX007; Dojolvi)	Long chain fatty acid oxidation disorders (LC-FAOD)	Endocrine Nutritional and Metabolic Disorders	2020	View \| Download
Triheptanoin (UX-007) for glucose transporter type 1 deficiency syndrome (de vivo disease) – first line	Triheptanoin (UX007; Dojolvi)	Glucose transporter type 1 deficiency syndrome	Endocrine Nutritional and Metabolic Disorders	2017	View \| Download
Trifluridine and Tipiracil for Metastatic Gastric Cancer – third line and above	Lonsurf; TAS-102 (fixed dose combination: Trifluridine; Tipiracil hydrochloride)	Gastric cancer , Gastro-oesophageal junction cancer	Gastrointestinal Cancer	2018	View \| Download
Treprostinil for chronic thromboembolic pulmonary hypertension	Hybrid treprostinil (Trepulmix)	Chronic thromboembolic pulmonary hypertension (CTEPH)	Cardiovascular System	2020	View \| Download
Treprostinil diethanolamine for treating pulmonary arterial hypertension	Treprostinil diethanolamine	Paroxysmal nocturnal haemoglobinuria	Cardiovascular System , Respiratory System	2022	View \| Download
Treosulfan in combination with fludarabine for paediatric non-malignant disease before allogeneic stem cell transplant	Fludarabine (fludarabine phosphate) , Treosulfan (Ovastat)	Non-malignant diseases	Endocrine Nutritional and Metabolic Disorders , Haematology , Immunology	2019	View \| Download
Treosulfan in combination with Fludarabine for Malignant and Non-Malignant diseases - prior to stem cell transplantation	Fludarabine (fludarabine phosphate) , Treosulfan (Ovastat)	Acute myeloid leukaemia (AML) , Myelodysplastic syndrome (MDS)	Haematological Cancer and Lymphomas	2018	View \| Download
Trastuzumab emtansine in combination with pertuzumab for HER2-positive early breast cancer - adjuvant therapy	Pertuzumab (Perjeta; R-1273) , Trastuzumab Emtansine (Kadcyla; T-DM1; PRO132365)	Breast cancer	Breast Cancer	2019	View \| Download
Trastuzumab Emtansine for HER2-positive breast cancer - adjuvant	Trastuzumab Emtansine (Kadcyla; T-DM1; PRO132365)	Breast cancer	Breast Cancer	2018	View \| Download